Why the fuss about long-acting antiretrovirals for HIV?

Posted in: Healthcare system, HIV, Latest, Opinions, Perspectives, Spotlight

HIV prevention injections that can provide two, or even six, months of protection per shot have arguably been the biggest HIV story of the year. Ahead of World AIDS Day, Professor Francois Venter assesses the state of play and the critical next steps with these potentially game-changing new tools in the fight against HIV.

Weight gain with new antiretrovirals: Its complicated

Posted in: HIV, Latest, Opinions

The ARV dolutegravir will soon become part of standard first line HIV treatment in South Africa. Two leading experts discuss what we do and do not know about dolutegravir and weight gain.

Mental health and pill-taking: Getting beyond HIV

Posted in: HIV, Latest, Opinions

Just as with HIV, every single one of us knows another person who is experiencing mental ill health. However, this may be hidden – due to stigma, shame, lack of understanding, and lack of adequate treatment, writes Professor Francois Venter.